CA2835053C - A method of increasing the productivity of eucaryotic cells in the production of recombinant fviii - Google Patents

A method of increasing the productivity of eucaryotic cells in the production of recombinant fviii Download PDF

Info

Publication number
CA2835053C
CA2835053C CA2835053A CA2835053A CA2835053C CA 2835053 C CA2835053 C CA 2835053C CA 2835053 A CA2835053 A CA 2835053A CA 2835053 A CA2835053 A CA 2835053A CA 2835053 C CA2835053 C CA 2835053C
Authority
CA
Canada
Prior art keywords
cells
cell
cell suspension
rfviii
increasing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2835053A
Other languages
English (en)
French (fr)
Other versions
CA2835053A1 (en
Inventor
Peter Aizawa
Irene Agerkvist
Original Assignee
Octapharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45470754&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2835053(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma AG filed Critical Octapharma AG
Publication of CA2835053A1 publication Critical patent/CA2835053A1/en
Application granted granted Critical
Publication of CA2835053C publication Critical patent/CA2835053C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C12M1/42—Apparatus for the treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00—Cells for large scale production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2521/00—Culture process characterised by the use of hydrostatic pressure, flow or shear forces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2527/00—Culture process characterised by the use of mechanical forces, e.g. strain, vibration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Sustainable Development (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
CA2835053A 2011-05-13 2012-05-14 A method of increasing the productivity of eucaryotic cells in the production of recombinant fviii Expired - Fee Related CA2835053C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP11166071.8 2011-05-13
EP11166071 2011-05-13
US201161489406P 2011-05-24 2011-05-24
US61/489,406 2011-05-24
PCT/EP2012/058899 WO2012156356A1 (en) 2011-05-13 2012-05-14 A method of increasing the productivity of eucaryotic cells in the production of recombinant fviii

Publications (2)

Publication Number Publication Date
CA2835053A1 CA2835053A1 (en) 2012-11-22
CA2835053C true CA2835053C (en) 2020-07-07

Family

ID=45470754

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2835053A Expired - Fee Related CA2835053C (en) 2011-05-13 2012-05-14 A method of increasing the productivity of eucaryotic cells in the production of recombinant fviii

Country Status (13)

Country Link
US (1) US9115381B2 (enExample)
EP (3) EP2707387B1 (enExample)
JP (1) JP6178786B2 (enExample)
KR (1) KR101980164B1 (enExample)
CN (1) CN103517919B (enExample)
AU (1) AU2012257736B2 (enExample)
BR (1) BR112013028006A2 (enExample)
CA (1) CA2835053C (enExample)
DK (1) DK3626737T3 (enExample)
ES (1) ES2970057T3 (enExample)
IL (1) IL229058A (enExample)
RU (1) RU2600886C2 (enExample)
WO (1) WO2012156356A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6591609B2 (en) 1997-07-15 2003-07-15 New Power Concepts Llc Regenerator for a Stirling Engine
CN106687575B (zh) 2014-06-04 2021-04-30 美国安进公司 用于收获哺乳动物细胞培养物的方法
CN107287265B (zh) * 2016-03-31 2018-09-14 正大天晴药业集团南京顺欣制药有限公司 一种制备重组人凝血因子ⅷ的方法
WO2020020364A1 (zh) * 2018-07-26 2020-01-30 正大天晴药业集团南京顺欣制药有限公司 一种制备重组人凝血因子ⅷ的方法
KR102903908B1 (ko) * 2020-05-20 2025-12-23 주식회사 엘지화학 전기 천공 장치 및 방법
CA3259418A1 (en) * 2022-06-15 2023-12-21 UCB Biopharma SRL CELL CULTURE PROCESSES
CN120005720B (zh) * 2025-04-21 2025-08-08 深圳市茵冠生物科技有限公司 一种人工智能的细胞培养监测方法及系统

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804420A (en) 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
US6358703B1 (en) * 1998-12-10 2002-03-19 Bayer Corporation Expression system for factor VIII
JP4674021B2 (ja) * 1999-07-13 2011-04-20 ビオヴィトルム・アクチボラゲット（プブリクト） 安定第ｖｉｉｉ因子組成物
DK1266006T3 (da) 2000-03-22 2006-01-16 Octagene Gmbh Fremstilling af rekombinante muteiner af blodkoagulationsfaktor VIII i humane cellelinier
CN104388324A (zh) * 2004-03-05 2015-03-04 帝斯曼知识产权资产管理有限公司 用于通过连续灌注和交互切向流来培养细胞的方法
JP2006296423A (ja) * 2005-03-24 2006-11-02 Hitachi Ltd 培養槽の制御装置及び培養装置
EP1707634A1 (en) * 2005-03-29 2006-10-04 Octapharma AG Method for isolation of recombinantly produced proteins
WO2006103298A2 (en) * 2005-04-01 2006-10-05 Novo Nordisk Health Care Ag Blood coagulation fviii analogues
EP1739179A1 (en) * 2005-06-30 2007-01-03 Octapharma AG Serum-free stable transfection and production of recombinant human proteins in human cell lines
DK2634242T3 (en) 2006-07-14 2017-05-22 Patheon Holdings I B V IMPROVED PROCEDURE FOR CULTURING CELLS
CN101490239A (zh) * 2006-07-14 2009-07-22 帝斯曼知识产权资产管理有限公司 改进的细胞培养方法
WO2009090787A1 (ja) * 2008-01-15 2009-07-23 Toray Industries, Inc. 生理活性ペプチドまたはタンパク質製造方法、および組換え動物細胞
EP2300497B1 (en) * 2008-06-24 2012-08-08 Octapharma AG A process of purifying coagulation factor viii
MX2011001624A (es) 2008-08-21 2011-03-28 Octapharma Ag Factor viii y ix humano producido en forma recombinante.
DE102008049120A1 (de) 2008-09-26 2010-04-01 Bayer Technology Services Gmbh Verfahren zur Reduzierung von Ablagerungen bei der Kultivierung von Organismen
EP2216395A1 (en) 2009-02-09 2010-08-11 Lonza Biologics plc. Bioreactor for the cultivation of mammalian cells
US8580554B2 (en) 2009-07-31 2013-11-12 Baxter International Inc. Method of producing a polypeptide or virus of interest in a continuous cell culture

Also Published As

Publication number Publication date
DK3626737T3 (da) 2024-02-05
JP6178786B2 (ja) 2017-08-09
IL229058A0 (en) 2013-12-31
US20140051123A1 (en) 2014-02-20
EP2707387A1 (en) 2014-03-19
CN103517919B (zh) 2016-11-16
RU2600886C2 (ru) 2016-10-27
KR101980164B1 (ko) 2019-05-20
IL229058A (en) 2017-03-30
EP2707387B1 (en) 2019-12-25
US9115381B2 (en) 2015-08-25
WO2012156356A1 (en) 2012-11-22
EP4353743A2 (en) 2024-04-17
AU2012257736A1 (en) 2013-10-10
EP3626737B1 (en) 2023-11-29
EP3626737A1 (en) 2020-03-25
CA2835053A1 (en) 2012-11-22
ES2970057T3 (es) 2024-05-24
EP4353743A3 (en) 2024-07-17
AU2012257736B2 (en) 2015-12-10
RU2013155382A (ru) 2015-06-20
CN103517919A (zh) 2014-01-15
JP2014513545A (ja) 2014-06-05
BR112013028006A2 (pt) 2016-09-06
KR20140021009A (ko) 2014-02-19

Similar Documents

Publication Publication Date Title
CA2835053C (en) A method of increasing the productivity of eucaryotic cells in the production of recombinant fviii
US20240247218A1 (en) Large scale pei-mediated plasmid transfection
Junne et al. How scalable and suitable are single-use bioreactors?
Reuveny Microcarrier culture systems
Birch et al. Suspension culture of mammalian cells
US8440800B2 (en) Compositions for reducing cell adhesion to bubbles
EA022219B1 (ru) Способ получения полипептида или вируса, представляющих интерес, в непрерывной клеточной культуре
US20200165557A1 (en) Large-Scale PEI-Mediated Plasmid Transfection
Fenge et al. Cell culture bioreactors
Kompala et al. Optimization of high cell density perfusion bioreactors
KR102570755B1 (ko) 고 세포 밀도의 유입 및 배출 발효 공정
JP2023503849A (ja) 接種物を生産するためのプロセスおよびシステム
Kuystermans et al. Bioreactor systems for producing antibody from mammalian cells
ES2777173T3 (es) Un procedimiento para aumentar la productividad de células eucarióticas en la producción de FVIII recombinante
Nilsson et al. [35] Entrapment of animal cells
Chalmers The challenges of hydrodynamic forces on cells used in cell manufacturing and therapy
Ahmed Application of hydrocyclone for cell separation in mammalian cell perfusion cultures
Hazari et al. Bioreactor design for vaccine production
Ryan Growing more cells: A simple guide to small volume cell culture scale-up
Heinzen Encapsulating Cells for High-Productivity Recombinant Protein Expression

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20170321

MKLA Lapsed

Effective date: 20210514